N. Satyamurthy

Publications258
h-index56
Citations13,078
Highly Influential Citations342
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • J. Barrio
  • 418 Publications • 16,375 Citations
  • M. Phelps
  • 923 Publications • 75,764 Citations
  • Sung-Cheng Huang
  • 327 Publications • 14,373 Citations
  • V. Kepe
  • 122 Publications • 5,520 Citations
  • Publications
  • Influence
PET of brain amyloid and tau in mild cognitive impairment.
TLDR
FDDNP-PET scanning can differentiate persons with mild cognitive impairment from those with Alzheimer's disease and those with no cognitive impairment, and this technique is potentially useful as a noninvasive method to determine regional cerebral patterns of amyloid plaques and tau neurofibrillary tangles.
Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET.
TLDR
The skeletal kinetics of [18F]fluoride ion with dynamic PET imaging is investigated to generate quantitative estimates of fluoride uptake (a "bone metabolic index") in focal skeletal regions or in more generalized distributions.
Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.
TLDR
This noninvasive technique for monitoring AP and NFT development is expected to facilitate diagnostic assessment of patients with AD and assist in response-monitoring during experimental treatments.
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
TLDR
18)F-FDOPA PET may prove especially useful for imaging of recurrent low-grade tumors and for distinguishing tumor recurrence from radiation necrosis, as determined by simple visual inspection, especially for the assessment of low- grade tumors.
Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease
TLDR
The high-affinity binding of the probes to multiple binding sites on fibrils are consistent with results obtained with digital autoradiography, immunohistochemistry, and confocal fluorescence microscopy using human brain specimens of AD patients.
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
TLDR
Thirty-minute PET of brain gliomas 5 min after injection was more sensitive than (18)F-FDG to image recurrent high-grade tumors, correlated better with Ki-67 values, and was a more powerful predictor of tumor progression and survival.
Serotonin 1A receptors in the living brain of Alzheimer's disease patients.
TLDR
A strong correlation of 5-HT(1A) receptor decreases in hippocampus with worsening of clinical symptoms (Mini Mental State Exam scores) was found and decreased glucose utilization as measured with 2-deoxy-2-[F-18]fluoro-d-glucose PET in the brains of Alzheimer's disease patients.
Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study.
TLDR
FLT- PET as an imaging biomarker seems to be predictive of overall survival in bevacizumab and irinotecan treatment of recurrent gliomas, and whether FLT-PET performed as early as 1 to 2 week after starting treatment is as predictive as the study indicates at 6 weeks warrants further investigation.
Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals
TLDR
A procedure to image reporter gene expression repetitively and non-invasively in living animals with positron emission tomography (PET), using the dopamine type 2 receptor (D2R) as a reporter gene and 3-(2′-[18F]fluoroethyl)spiperone (FESP) as the reporter probe.
Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression.
TLDR
(18)F]FHBG has the desirable in vivo characteristics of stability, rapid blood clearance, low background signal, biosafety, and acceptable radiation dosimetry in humans.
...
1
2
3
4
5
...